Van Nguyen Hung, Nguyen Huong Lan Thi, Mai Hue Thi, Le Hai Quan, Tran Bach Xuan, Hoang Canh Dinh, Le Huong Thi, Nguyen Cuong Tat, Tran Tho Dinh, Latkin Carl A, Vu Thuc Minh Thi
Authority of HIV/AIDS Control, Ministry of Health, Hanoi, Vietnam.
Institute for Global Health Innovations, Duy Tan University, Da Nang, Vietnam.
Harm Reduct J. 2017 Jan 6;14(1):1. doi: 10.1186/s12954-016-0127-9.
Stigma and discrimination may adversely affect the benefits of methadone maintenance treatment (MMT) for drug users, especially in disadvantaged settings. This study assessed stigma and discrimination against MMT patients in the mountainous and rural areas in Vietnam and explored their associated factors to inform implementation strategies.
We interviewed 241 MMT patients in two clinics: one in Tuyen Quang Province's inner city and the other in Son Duong District, to assess stigma and discrimination that patients perceived and experienced. Socioeconomic status, health behaviors, health status, and history of drug abuse were examined. Multivariate linear and logistic regression models were used to explore factors associated with stigma and discrimination.
The majority of respondents reported experiencing stigma and discrimination including blame/judgment (95.1%), shame (95.1%), disclosure (71.4%), and the fear of human immunodeficiency virus (HIV) transmission by others (74.1%). Unemployed patients were more likely to experience discrimination (Coef = -1.18, 95% CI = -1.87; -0.89). Those who were taking an antiretroviral were more likely to disclose their health status (Coef = 2.27, 95% CI = 0.6; 3.94). In addition, a higher likelihood of being blamed/judged and shamed was associated with those who suffered from anxiety/depression (Coef = 1.59, 95% CI = 0.24; 2.93 and Coef = 1.07, 95% CI = 0.36; 1.79, respectively).
MMT patients in these mountainous areas perceived high levels of stigma and discrimination which were associated with mental health disorders, unemployment, and HIV infection. These findings highlighted the importance of reducing drug use and HIV-related stigma against high-risk populations. Besides, psychosocial and familial supports, as well as job referrals, also play crucial roles in terms of promoting quality of life among MMT patients.
耻辱感和歧视可能会对吸毒者美沙酮维持治疗(MMT)的益处产生不利影响,尤其是在条件不利的环境中。本研究评估了越南山区和农村地区对MMT患者的耻辱感和歧视情况,并探讨了其相关因素,以为实施策略提供参考。
我们在两家诊所采访了241名MMT患者,一家位于宣光省的市中心,另一家位于山阳县,以评估患者感知到的和经历的耻辱感和歧视。对社会经济状况、健康行为、健康状况和药物滥用史进行了调查。使用多元线性和逻辑回归模型探索与耻辱感和歧视相关的因素。
大多数受访者报告称经历过耻辱感和歧视,包括指责/评判(95.1%)、羞耻(95.1%)、信息披露(71.4%)以及担心他人传播人类免疫缺陷病毒(HIV)(74.1%)。失业患者更有可能遭受歧视(系数=-1.18,95%置信区间=-1.87;-0.89)。正在接受抗逆转录病毒治疗的患者更有可能披露自己的健康状况(系数=2.27,95%置信区间=0.6;3.94)。此外,患有焦虑/抑郁的患者更有可能被指责/评判和感到羞耻(系数分别为1.59,95%置信区间=0.24;2.93和系数=1.07,95%置信区间=0.36;1.79)。
这些山区的MMT患者感受到了较高程度的耻辱感和歧视,这与心理健康障碍、失业和HIV感染有关。这些发现凸显了减少对高危人群的药物使用和与HIV相关的耻辱感的重要性。此外,心理社会和家庭支持以及工作推荐在提高MMT患者的生活质量方面也起着至关重要的作用。